Development and initial testing of the stroke rapid-treatment readiness tool.
Abstract
No instruments are currently available to help health systems identify target areas
for reducing door-to-needle times for the administration of intravenous tissue plasminogen
activator to eligible patients with ischemic stroke. A 67-item Likert-scale survey
was administered by telephone to stroke personnel at 252 U.S. hospitals participating
in the "Get With The Guidelines-Stroke" quality improvement program. Factor analysis
was used to refine the instrument to a four-factor 29-item instrument that can be
used by hospitals to assess their readiness to administer intravenous tissue plasminogen
activator within 60 minutes of patient hospital arrival.
Type
Journal articleSubject
Cerebral InfarctionEarly Medical Intervention
Efficiency, Organizational
Guideline Adherence
Humans
Infusions, Intravenous
Patient Admission
Patient Care Team
Quality Improvement
Thrombolytic Therapy
Time and Motion Studies
Tissue Plasminogen Activator
Workflow
Permalink
https://hdl.handle.net/10161/15006Published Version (Please cite this version)
10.1097/JNN.0000000000000082Publication Info
(2014). Development and initial testing of the stroke rapid-treatment readiness tool. J Neurosci Nurs, 46(5). pp. 267-273. 10.1097/JNN.0000000000000082. Retrieved from https://hdl.handle.net/10161/15006.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Eric David Peterson
Fred Cobb, M.D. Distinguished Professor of Medicine
Dr Peterson is the Fred Cobb Distinguished Professor of Medicine in the Division of
Cardiology, a DukeMed Scholar, and the Past Executive Director of the Duke Clinical
Research Institute (DCRI), Durham, NC, USA.
Dr Peterson is the Principal Investigator of the National Institute of Health, Lung
and Blood Institute (NHLBI) Spironolactone Initiation Registry Randomized Interventional
Trial in Heart Failure With Preserved Ejection Fraction (SPIRRIT) Trial He is also
the Principal I
This author no longer has a Scholars@Duke profile, so the information shown here reflects
their Duke status at the time this item was deposited.
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info